•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.How to Invest in AI Drug Discovery
Tecan Group AG (TCGGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Tecan Group AG (TCGGY) Q2 2026 Earnings Call Transcript
Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA
Q1 2026 Update: Tecan on track with low-single-digit local currency growth in Q1; full-year 2026 outlook confirmed
Update zum 1. Quartal 2026: Tecan auf Kurs mit Umsatzwachstum im niedrigen einstelligen Bereich in Lokalwährungen; Ausblick für das Gesamtjahr 2026 bestätigt
Camila Japur joins Tecan as Chief Financial Officer
Tecan to create Data-Driven Labs with NVIDIA
Tecan Group AG (TCGGY) Analyst/Investor Day Transcript
Tecan präsentiert Ergebnisse 2025 und stellt Programm zur Rückkehr zu profitablem Wachstum vor
Tecan presents 2025 results and provides details on program to reignite profitable growth
Tecan Group AG (TCGGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Tecan meldet Rückkehr zum Umsatzwachstum und starken Auftragseingang im zweiten Halbjahr 2025
Tecan reports return to sales growth and strong order entry in the second half of 2025
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
Tecan Group AG (TCHBF) Q2 2025 Earnings Call Transcript
Tecan Group AG (TCHBF) Q4 2024 Earnings Call Transcript
Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
Tecan Group AG (TCHBF) Q4 2023 Earnings Call Transcript
Already premium?